Canadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's booster, was 75.3 per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday .
"These are encouraging results given data were obtained in an environment with no ancestral virus circulating. The global COVID-19 pandemic is continuing to show new facets with the current dominance of the Delta variant, upcoming Omicron, and other variants likely to follow," GSK Chief Global Health Officer Thomas Breuer said in a statement.
Medicago will imminently seek regulatory approval for the world's first plant-based COVID-19 vaccine from Health Canada as part of its rolling submission.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Medicago's plant-based vaccine trial shows 75.3per cent efficacy against Delta variantCanadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's booster, was 75.3per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday.They said the vaccine's overall efficacy rate against all variants of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Medicago's plant-based vaccine trial shows 75.3per cent efficacy against Delta variantCanadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's booster, was 75.3per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday.They said the vaccine's overall efficacy rate against all variants of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Too early to determine Omicron's severity, but experts say current vaccines offer protection: MOHIt is too early to say for sure how severe the Omicron coronavirus variant is, but there is an emerging view among scientists that existing Covid-19 vaccines will still work...
Source: thenewpaper - 🏆 7. / 63 Read more »
Inside the race to test omicron's true threatMicrobiologist Pei-Yong Shi has studied all the variants: alpha, beta, gamma, delta, 'delta-plus,' lambda and mu. So he was ready for omicron, the variant that incited global anxiety unlike any of the variants that came before. Like most scientists, he was shocked by the sheer number of mutations. He also knew exactly what to do next.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Shi runs a high-containment laboratory at the Univers
Source: YahooSG - 🏆 3. / 71 Read more »
Cambodian mass trial against government opponents reopensPHNOM PENH: A mass trial of critics and opponents of Cambodia’s government charged with treason for their non-violent political activities resumed on Tuesday (Dec 7), amid an ongoing crackdown on dissent. Only six of 44 defendants summoned by the Phnom Penh Municipal Court turned up at Tuesday’s trial
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Omicron v. delta: Battle of coronavirus mutants is criticalAs the omicron coronavirus variant spreads in southern Africa and pops up in countries all around the world, scientists are anxiously watching a battle play out that could determine the future of the pandemic. Can the latest competitor to the world-dominating delta overthrow it? “It’s still early days, but increasingly, data is starting to trickle in, suggesting that omicron is likely to outcompete delta in many, if not all, places,” said Dr. Jacob Lemieux, who monitors variants for a research collaboration led by Harvard Medical School.
Source: YahooSG - 🏆 3. / 71 Read more »